Early Phase 1 Brain Cancer Trial, Recruiting NCT05555550 Sponsor: Children's Hospital of Philadelphia Condition: Brain Cancer
Back to Brain Cancer

Early Phase 1 Brain Cancer Trial, Recruiting

NCT05555550
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a low-grade brain tumour (Grade I or II) located in the brainstem or the upper part of the brain, confirmed by a biopsy (or, for those with a condition called NF1, by the typical appearance of the tumour on scans).
  • People whose tumour measures at least 1 cm x 1 cm on an MRI scan.
  • People who are already scheduled to receive systemic (whole-body) treatment for their low-grade brain tumour.
  • People who have a general health and functioning score of at least 50 out of 100, as rated by their doctor using standard medical scales (people who use a wheelchair but are otherwise up and about may still meet this requirement — confirm with trial site).
  • People who are aged between 1 and 21 years old at the time of registration.
  • People who are already on a treatment plan are still eligible to be considered for this trial.

Who may not be able to join:

  • People who, in their doctor's opinion, would not be able to tolerate the imaging procedures required by the trial.
  • People who are pregnant.
  • People who weigh less than 8 kilograms.
  • People who cannot avoid being in contact with a pregnant woman or an infant for at least 12 hours after receiving the trial injection.
  • People who have a history of abnormal kidney function, or whose kidney function test results are significantly outside the normal range at the time of registration.
  • People whose tumour started in the spinal cord.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Mariam Aboian, MD,PhD, The Children s Hospital of Philadelphia

Phone: 215-510-7661

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Children's Hospital of Philadelphia
Registry
ClinicalTrials.gov
Start date
29 July 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Compare change in standardized uptake value parameters (SUVmax and SUVpeak) on metabolic tumor volume in 18F-Fluciclovine PET; Compare changes in pretreatment tumor measurement on MRI in pediatric participants who initiate systemic treatment for LGG

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov